Magnetar Financial’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-122,600
Closed -$2K 486
2018
Q4
$2K Buy
+122,600
New +$20.1M ﹤0.01% 273
2016
Q2
Sell
-200,000
Closed -$53.6M 515
2016
Q1
$53.6M Buy
200,000
+150,000
+300% +$42.9M 0.83% 45
2015
Q4
$15.6M Buy
+50,000
New +$14.9M 0.18% 74
2015
Q1
Sell
-302,400
Closed -$77.8M 262
2014
Q4
$77.8M Buy
302,400
+150,400
+99% +$37.6M 1.24% 27
2014
Q3
$36.7M Sell
152,000
-58,000
-28% -$13M 0.61% 50
2014
Q2
$46.8M Buy
+210,000
New +$43.5M 0.78% 49
2013
Q4
Sell
-5,000
Closed -$720K 448
2013
Q3
$720K Sell
5,000
-320,000
-98% -$42.6M 0.01% 339
2013
Q2
$41M Buy
+325,000
New +$36.8M 0.9% 34

Other funds holding AGN

Magnetar Financial's AGN Position: Q2 2020 in Review

Magnetar Financial sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,356,014 shares — an estimated $240M sold.

Magnetar Financial first reported a position in AGN in Q2 2013 and held it in 21 quarters. The position peaked at $243M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Magnetar Financial reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Magnetar Financial sold 1,356,014 Allergan plc shares in Q2 2020, an estimated $240M.
  • Magnetar Financial first reported a position in Allergan plc in Q2 2013 and held it in 21 quarters.
  • Magnetar Financial's Allergan plc position peaked at $243M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Magnetar Financial's 13F filing for Q2 2020, filed 14 Aug 2020.